obicetrapib + ezetimibe

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

OBICETRAPIB AND EZETIMIBE COMBINATION TREATMENT AND FIXED DOSE PHARMACEUTICAL COMPOSITIONS
- EP 4661865 A1
  申请人: NEWAMSTERDAM PHARMA B V优先权: 2023
  EP
  US
  WO
  3 件公开
- EP 4577207 A1
  申请人: NEWAMSTERDAM PHARMA B V优先权: 2022
  EP
- WO 2026109563 A1
  申请人: NEWAMSTERDAM PHARMA B V优先权: 2024
  WO
- US 20250186442 A1
  申请人: NEWAMSTERDAM PHARMA B V优先权: 2025
  US
FIXED DOSE COMBINATION COMPOSITION OF OBICETRAPIB AND EZETIMIBE
WO 2025147235 A1申请人: NEWAMSTERDAM PHARMA B V优先权: 2024
CN
WO
2 件公开
Combination Therapy of Obicetrapib and Ezetimibe for Use in Statin Intolerant Patients Suffering from Hyperlipidemia or Mixed Dyslipidaemia
US 2024189311 A1申请人: NEWAMSTERDAM PHARMA B V优先权: 2021
US
PHARMACEUTICAL COMPOSITIONS OF OBICETRAPIB AND EZETIMIBE
WO 2025146445 A1申请人: NEWAMSTERDAM PHARMA B V优先权: 2024
WO
IMPROVEMENT IN ATHEROSCLEROTIC PLAQUE CHARACTERISTICS WITH OBICETRAPIB
WO 2025146415 A1申请人: NEWAMSTERDAM PHARMA B V优先权: 2024
WO